Current position:Home >Product >
2,4-Pentadienamide, N-[2-(diphenylmethoxy)ethyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)-
2,4-Pentadienamide, N-[2-(diphenylmethoxy)ethyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)-(101618-83-1)
- Name: 2,4-Pentadienamide, N-[2-(diphenylmethoxy)ethyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)-
- Synonyms:
- Molecular Formula:C27H27NO4
- Molecular Weight:
- CAS Registry Number:101618-83-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 101618-59-1/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
- 101618-60-4/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo -7H-purin-7-yl)ethyl]-, (E)-
- 101618-61-5/Piperazine, 1-[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-4-[2-(diphenylmethoxy)eth yl]-, (E)-
- 101618-62-6/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[2-(diphenylmethoxy)ethyl]-, (E)-
- 101618-63-7/2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2, 6-dioxo-7H-purin-7-yl)ethyl]-, (E)-
- 101618-64-8/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2- propenyl]-, (E)-
- 101618-65-9/Piperazine, 1-[3-(diphenylmethoxy)propyl]-4-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo- 2-propenyl]-, (E)-
- 101618-66-0/2-Propenamide, N-[2-(diphenylmethoxy)ethyl]-3-(4-hydroxy-3-methoxyphenyl)-, (E)-
- 101618-67-1/2-Propenamide, N-[3-(diphenylmethoxy)propyl]-3-(4-hydroxy-3-methoxyphenyl)-, (E)-
- 101618-68-2/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
- 101618-69-3/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-diox o-7H-purin-7-yl)butyl]-, (E)-
- 101618-71-7/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[2-(diphenylmethoxy)ethyl]-, (E)-
- 101618-72-8/2-Propenamide, N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(4-hydroxy-3,5-dimethoxy phenyl)-, (E)-
- 101618-73-9/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-hydroxy-3,5-dimethoxyphenyl)-1-ox o-2-propenyl]-, (E)-
- 101618-75-1/2-Propenamide, N-[2-(diphenylmethoxy)ethyl]-3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-
- 101618-76-2/2,4-Pentadienamide, 5-(3,4-dihydroxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E,E)-
- 101618-79-5/2,4-Pentadienamide, N-[4-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]butyl]-5-(4-hydroxy- 3-methoxyphenyl)-, (E,E)-
- 101618-81-9/2,4-Pentadienamide, 5-(4-hydroxy-3-methoxyphenyl)-N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2, 6-dioxo-7H-purin-7-yl)ethyl]-, (E,E)-
- 101618-82-0/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[5-(4-hydroxy-3-methoxyphenyl)-1-oxo-2, 4-pentadienyl]-, (E,E)-
- 101618-83-1/2,4-Pentadienamide, N-[2-(diphenylmethoxy)ethyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)-
- 101618-84-2/2,4-Pentadienamide, N-[3-(diphenylmethoxy)propyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)-
- 101618-85-3/2,4-Pentadienamide, 5-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E,E)-
- 101618-87-5/2,4-Pentadienamide, N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)ethyl]-5-(3 ,4,5-trimethoxyphenyl)-, (E,E)-
- 101618-88-6/2,4-Pentadienamide, N-[4-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]butyl]-5-(4-hydroxy- 3,5-dimethoxyphenyl)-, (E,E)-
- 101618-89-7/2,4-Pentadienamide, N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-5-(4-hydroxy-3,5-dimethoxy phenyl)-, (E,E)-
- 101618-90-0/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[5-(4-hydroxy-3,5-dimethoxyphenyl)-1-ox o-2,4-pentadienyl]-, (E,E)-
- 101618-92-2/2,4-Pentadienamide, N-[2-(diphenylmethoxy)ethyl]-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (E,E)-
- 101618-93-3/Piperazine, 1-[3-[1-(4-chlorophenyl)-1-phenylethoxy]propyl]-4-[3-(3,4-dihydroxyphen yl)-1-oxo-2-propenyl]-, (E)-
- 101618-94-4/Piperazine, 1-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-4-[3-(4-hydroxy-3-methoxy phenyl)-1-oxo-2-propenyl]-, (E)-
- 101618-96-6/Piperazine, 1-[3-[1-(4-chlorophenyl)-1-phenylethoxy]propyl]-4-[3-(3,4-dimethoxyphen yl)-1-oxo-2-propenyl]-, (E)-